AgingResearch.NewsJoin free

Centro A.F. de Estudios Tecnologicos

CompanyMexico

Centro A.F. de Estudios Tecnologicos develops one asset, approved (Estradiol and Progesterone in menopausal symptoms). Mostly small molecule acting on ESR1, ESR2 and PGR; based in Mexico.

1
Asset
Furthest stage
Approved
1
Trial
40
Signals

Pipeline

1

  • Estradiol and Progesterone

    Hormone replacement therapy activating estrogen and progesterone nuclear receptors to manage menopausal symptoms.

    Approved, Small molecule, ESR1, ESR2, menopausal symptoms, menopause (Phase 3)

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms5
  • Trials1
  • Signals20
  • Similar companies6

Intelligence